<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>1082</number>
    <updateDate>2025-11-06T16:50:11Z</updateDate>
    <updateDateIncludingText>2025-11-06T16:50:11Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2025-02-06</introducedDate>
    <congress>119</congress>
    <legislationUrl>https://www.congress.gov/bill/119th-congress/house-bill/1082</legislationUrl>
    <cdata/>
    <committees>
      <item>
        <systemCode>sshr00</systemCode>
        <name>Health, Education, Labor, and Pensions Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2025-06-24T21:00:54Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Reported By</name>
            <date>2025-06-12T22:17:40Z</date>
          </item>
          <item>
            <name>Markup By</name>
            <date>2025-04-29T22:10:07Z</date>
          </item>
          <item>
            <name>Referred To</name>
            <date>2025-02-06T15:05:05Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <committeeReports>
      <committeeReport>
        <citation>H. Rept. 119-160</citation>
      </committeeReport>
    </committeeReports>
    <relatedBills>
      <item>
        <title>The HCT/P Modernization Act of 2025</title>
        <congress>119</congress>
        <number>340</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2025-01-13</actionDate>
          <text>Referred to the House Committee on Energy and Commerce.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2025-06-24</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2025-06-23</actionDate>
        <actionTime>15:51:45</actionTime>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <type>Floor</type>
        <actionCode>H38310</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2025-06-23</actionDate>
        <actionTime>15:51:44</actionTime>
        <text>On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)</text>
        <type>Floor</type>
        <actionCode>H37300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2025-06-23</actionDate>
        <actionTime>15:51:44</actionTime>
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)</text>
        <type>Floor</type>
        <actionCode>8000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2025-06-23</actionDate>
        <actionTime>15:39:27</actionTime>
        <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 1082.</text>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2025-06-23</actionDate>
        <actionTime>15:39:26</actionTime>
        <text>Considered under suspension of the rules. (consideration: CR H2860-2862)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2025-06-23</actionDate>
        <actionTime>15:39:04</actionTime>
        <text>Mr. Bilirakis moved to suspend the rules and pass the bill.</text>
        <type>Floor</type>
        <actionCode>H30300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2025-06-12</actionDate>
        <text>Placed on the Union Calendar, Calendar No. 127.</text>
        <type>Calendars</type>
        <actionCode>H12410</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <calendarNumber>
          <calendar>U00127</calendar>
        </calendarNumber>
      </item>
      <item>
        <actionDate>2025-06-12</actionDate>
        <text>Reported by the Committee on Energy and Commerce. H. Rept. 119-160.</text>
        <type>Committee</type>
        <actionCode>H12200</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2025-06-12</actionDate>
        <text>Reported by the Committee on Energy and Commerce. H. Rept. 119-160.</text>
        <type>Committee</type>
        <actionCode>5000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2025-04-29</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Ordered to be Reported by Voice Vote.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2025-04-29</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2025-02-06</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2025-02-06</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2025-02-06</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>M001194</bioguideId>
        <fullName>Rep. Moolenaar, John R. [R-MI-2]</fullName>
        <firstName>John</firstName>
        <lastName>Moolenaar</lastName>
        <party>R</party>
        <state>MI</state>
        <middleName>R.</middleName>
        <district>2</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>D000624</bioguideId>
        <fullName>Rep. Dingell, Debbie [D-MI-6]</fullName>
        <firstName>Debbie</firstName>
        <lastName>Dingell</lastName>
        <party>D</party>
        <state>MI</state>
        <district>6</district>
        <sponsorshipDate>2025-02-06</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <cboCostEstimates>
      <item>
        <pubDate>2025-11-06T16:43:00Z</pubDate>
        <title>H.R. 1082, Shandra Eisenga Human Cell and Tissue Product Safety Act</title>
        <url>https://www.cbo.gov/publication/61876</url>
        <description>As passed by the House of Representatives on June 23, 2025</description>
      </item>
    </cboCostEstimates>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative law and regulatory procedures</name>
          <updateDate>2025-04-24T15:51:04Z</updateDate>
        </item>
        <item>
          <name>Civil actions and liability</name>
          <updateDate>2025-04-24T15:51:04Z</updateDate>
        </item>
        <item>
          <name>Congressional oversight</name>
          <updateDate>2025-04-24T15:51:04Z</updateDate>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
          <updateDate>2025-04-24T15:51:04Z</updateDate>
        </item>
        <item>
          <name>Health programs administration and funding</name>
          <updateDate>2025-04-24T15:51:04Z</updateDate>
        </item>
        <item>
          <name>Health promotion and preventive care</name>
          <updateDate>2025-04-24T15:51:04Z</updateDate>
        </item>
        <item>
          <name>Organ and tissue donation and transplantation</name>
          <updateDate>2025-04-24T15:51:04Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2025-03-12T13:03:33Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2025-02-06</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2025-06-18T18:05:24Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;strong&gt;Shandra Eisenga Human Cell and Tissue Product Safety Act&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;This bill establishes civil penalties for violations of regulations governing the donation and handling of human cell and tissue products. It also&amp;nbsp;requires the Food and Drug Administration (FDA) to report on the regulation of these products and to provide related information to stakeholders. (&lt;em&gt;Human cell and tissue products&lt;/em&gt; are articles containing or consisting of human cells or tissues that are intended for use in a human recipient.)&lt;/p&gt;&lt;p&gt;Specifically, the bill establishes civil penalties for violations of the FDAâ€™s regulations on donor eligibility and current good tissue practice for manufacturing and distributing&amp;nbsp;human cell and tissue products.&lt;/p&gt;&lt;p&gt;Also, the bill requires the FDA to conduct workshops to educate stakeholders and facilitate discussion on the science and regulation of human cell and tissue products. The FDA must establish a public docket to receive written comments on this topic, and report to Congress with recommendations. The bill also requires the FDA to support the development of educational materials for health care  professionals regarding organ, tissue, and eye donations and related topics.&lt;/p&gt;&lt;p&gt;Additionally, the bill requires the FDA to publish on its website educational materials about the Tissue Reference Group (a working group within the FDA)&amp;nbsp;and best practices for obtaining a recommendation from them about human cell and tissue products. Also, annually for three years, the FDA must publish on its website information on inquiries submitted to the Tissue Reference Group and FDA registrations and inspections regarding human cell and&amp;nbsp;tissue manufacturers.&amp;nbsp;&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>Shandra Eisenga Human Cell and Tissue Product Safety Act</title>
    <titles>
      <item>
        <titleType>Short Titles from RFS (Referred to Senate) bill text</titleType>
        <titleTypeCode>255</titleTypeCode>
        <title>Shandra Eisenga Human Cell and Tissue Product Safety Act</title>
        <updateDate>2025-06-26T06:53:19Z</updateDate>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
        <billTextVersionName>Referred in Senate</billTextVersionName>
        <billTextVersionCode>RFS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Passed House</titleType>
        <titleTypeCode>104</titleTypeCode>
        <title>Shandra Eisenga Human Cell and Tissue Product Safety Act</title>
        <updateDate>2025-06-25T03:08:16Z</updateDate>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Engrossed in House</billTextVersionName>
        <billTextVersionCode>EH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to House</titleType>
        <titleTypeCode>102</titleTypeCode>
        <title>Shandra Eisenga Human Cell and Tissue Product Safety Act</title>
        <updateDate>2025-06-13T05:53:16Z</updateDate>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Reported in House</billTextVersionName>
        <billTextVersionCode>RH</billTextVersionCode>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Shandra Eisenga Human Cell and Tissue Product Safety Act</title>
        <updateDate>2025-03-11T05:23:20Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Shandra Eisenga Human Cell and Tissue Product Safety Act</title>
        <updateDate>2025-03-11T05:23:19Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To require the Secretary of Health and Human Services to conduct a national, evidence-based education campaign to increase public and health care provider awareness regarding the potential risks and benefits of human cell and tissue products transplants, and for other purposes.</title>
        <updateDate>2025-03-11T05:18:30Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Referred in Senate</type>
        <date>2025-06-24T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-119hr1082rfs/xml/BILLS-119hr1082rfs.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Engrossed in House</type>
        <date>2025-06-23T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-119hr1082eh/xml/BILLS-119hr1082eh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Reported in House</type>
        <date>2025-06-12T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-119hr1082rh/xml/BILLS-119hr1082rh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in House</type>
        <date>2025-02-06T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-119hr1082ih/xml/BILLS-119hr1082ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2025-06-24</actionDate>
      <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
